FDA Inspection 1151448 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on August 12, 2021 in Richmond, VA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 12, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Richmond, VA (United States)